Partnership Potential Leverage Apricus existing marketing partnerships for Vitaros in Europe and Canada to explore regional co-promotion, distribution deals, or exclusive licensing opportunities with additional partners in new markets or adjacent urology indications.

Pipeline Upsell Explore cross-sell opportunities from Vitaros to patients with ED who may benefit from RayVa for Raynaud’s-inspired vascular concerns, or from fispemifene in male hypogonadism to urology clinics treating related conditions, aligning with current Phase 2b activities.

Geographic Expansion Target expansion into markets where Vitaros is already approved or under development, using existing European partners as a blueprint to enter additional European countries and potential nearby regions with similar regulatory pathways.

Clinical Collaboration Engage with Apricus R&D to identify co-development or sponsored research opportunities around their Phase 2 programs, offering Clinical Trial Collaboration, patient recruitment partnerships, or funded studies in urology and rheumatology segments.

Financial & Strategic Fit Position as a potential strategic partner or investor by aligning with Apricus’ small-company scale and revenue profile, proposing channel investments, milestone-based collaborations, or project-based funding tied to progression of RayVa, fispemifene, or second-generation Vitaros development.